Please visit our News & Updates. Sign up here to receive news updates via email. In the meantime, check out our YouTube channel!
Mitochondrial dysfunction underpins multiple high-burden diseases.
Clinical Trials
BPGbio’s lead program, BPM31510, anchors a growing clinical-stage pipeline designed to address diseases driven by mitochondrial dysfunction.
Primary CoQ10 Deficiency (PCQD) Glioblastoma (GBM) Pancreatic Cancer Epidermolysis Bullosa (EB) Sarcopenia
Patents
With over 400 US and international patents, BPGbio’s intellectual property portfolio reinforces our leadership in bioscience, offering partners and investors a foundation of exclusivity and fostering revolutionary advancements in the healthcare landscape.
Partner with Us
We invite forward-thinking organizations to partner with us. Whether it’s licensing our assets or harnessing the power of our Mito Platform, we’re committed to creating strong relationships that drive success.
